Recently, Rivas and coworkers developed an ex vivo 3D model of HER2-positive BC that recapitulates patients’ response to treatment, consisting of fluorescent human HER2-positive BC cells co-cultured with patient-derived fibroblasts and naïve primary immune cells collected from the peripheral blood of healthy donors (96). The gene discussed is ERBB2; the disease is breast cancer.